Company Announcement no. 27/2014
To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 16 December 2014
Veloxis Pharmaceuticals Announces Financial Calendar for 2015
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced financial calendar for 2015.
4. March, 2015: Release of Annual Report 2014.
26 March, 2015: Annual General Meeting.
20 May, 2015: Interim Report for the 1st Quarter ‐ for the period 1 January to 31 March, 2015.
26 August, 2015: Interim Report for the 2nd Quarter – for the period 1 January to 30 June, 2015.
11 November, 2015: Interim Report for the 3rd Quarter – for the period 1 January to 30 September, 2015.
For more information, please contact:
Veloxis Pharmaceuticals A/S
Bill Polvino Johnny Stilou
President & CEO EVP, Chief Financial Officer
Mobile: +1 917 647 9107 Mobile: +45 21 227 227
Email: wjp@veloxis.com Email: jst@veloxis.com
About Veloxis Pharmaceuticals
Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis’ unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.
For further information, please visit www.veloxis.com.